Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soldano Ferrone

Showing results (51-60 of 334) with videos related to

Pageof 34
Sort By:
Oral Oncology|June 7, 2016
Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cellsFernando Concha-Benavente, Raghvendra Srivastava, Soldano Ferrone, et al.
Head & Neck|September 18, 2010
Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neckKazuaki Chikamatsu, Goro Takahashi, Koichi Sakakura, et al.
Journal of Translational Medicine|May 20, 2004
Lost in Translation: Obstacles to Translational MedicineStacey P Mankoff, Christian Brander, Soldano Ferrone, et al.
Cancer Research|November 17, 2005
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?Nathalie Rouas-Freiss, Philippe Moreau, Soldano Ferrone, et al.
Clinical Transplants|August 7, 2014
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cellsFrancesco Sabbatino, Joseph H Schwab, Soldano Ferrone, et al.
Trends in Immunology|June 18, 2003
Tumors as elusive targets of T-cell-based active immunotherapyFrancesco M Marincola, Ena Wang, Meenhard Herlyn, et al.
Expert Opinion on Emerging Drugs|October 1, 2013
Emerging BRAF inhibitors for melanomaFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.
Drug Discovery Today|November 11, 2022
Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapyAhmed O Elzoghby, Cristina R Ferrone, Soldano Ferrone, et al.
The Journal of Urology|January 10, 2004
Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?Derek Atkins, Soldano Ferrone, Gerd E Schmahl, et al.
Current Medicinal Chemistry|March 7, 2019
B7-H3-targeted Radioimmunotherapy of Human CancerBenjamin B Kasten, Soldano Ferrone, Kurt R Zinn, et al.
Pageof 34

Showing results (51-60 of 334) with videos related to

Sort By:
Pageof 34
Oral Oncology|June 7, 2016
Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cellsFernando Concha-Benavente, Raghvendra Srivastava, Soldano Ferrone, et al.
Head & Neck|September 18, 2010
Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neckKazuaki Chikamatsu, Goro Takahashi, Koichi Sakakura, et al.
Journal of Translational Medicine|May 20, 2004
Lost in Translation: Obstacles to Translational MedicineStacey P Mankoff, Christian Brander, Soldano Ferrone, et al.
Cancer Research|November 17, 2005
HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?Nathalie Rouas-Freiss, Philippe Moreau, Soldano Ferrone, et al.
Clinical Transplants|August 7, 2014
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cellsFrancesco Sabbatino, Joseph H Schwab, Soldano Ferrone, et al.
Trends in Immunology|June 18, 2003
Tumors as elusive targets of T-cell-based active immunotherapyFrancesco M Marincola, Ena Wang, Meenhard Herlyn, et al.
Expert Opinion on Emerging Drugs|October 1, 2013
Emerging BRAF inhibitors for melanomaFrancesco Sabbatino, Yangyang Wang, Xinhui Wang, et al.
Drug Discovery Today|November 11, 2022
Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapyAhmed O Elzoghby, Cristina R Ferrone, Soldano Ferrone, et al.
The Journal of Urology|January 10, 2004
Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?Derek Atkins, Soldano Ferrone, Gerd E Schmahl, et al.
Current Medicinal Chemistry|March 7, 2019
B7-H3-targeted Radioimmunotherapy of Human CancerBenjamin B Kasten, Soldano Ferrone, Kurt R Zinn, et al.
Pageof 34